Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Frequency Therapeutics Inc (FREQ)

Frequency Therapeutics Inc (FREQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Frequency Therapeutics Inc 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 USA

www.frequencytx.com P: 781-315-4600

Description:

Frequency Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company's lead product candidate, FX-322, is in clinical development and is designed to regenerate auditory hair cells to restore hearing function in patients with sensorineural hearing loss. Frequency Therapeutics Inc. is headquartered in Woburn, Mass.

Key Statistics

Overview:

Market Capitalization, $K 10,942
Enterprise Value, $K -26,838
Shares Outstanding, K 36,521
Annual Sales, $ 0 K
Annual Net Income, $ -81,580 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,800 K
EBIT, $ -70,820 K
EBITDA, $ -68,050 K
60-Month Beta 0.84
% of Insider Shareholders 16.80%
% of Institutional Shareholders 13.18%
Float, K 30,385
% Float 83.20%
Short Volume Ratio 0.26

Growth:

1-Year Return -87.20%
3-Year Return -98.71%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 08/10/23
Latest Earnings Date 11/14/23
Earnings Per Share ttm -1.89
EPS Growth vs. Prev Qtr 45.45%
EPS Growth vs. Prev Year 50.82%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 11/06/23

FREQ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -107.67%
Return-on-Assets % -61.39%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.24
Book Value/Share 1.27
Interest Coverage -83.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar